Re: Not going anywhere.... aquisition valuation are usualy some percent markup
of previous 30 -60 average share price. the chart
is indicative of accumalation. there is value here
for short term gain . Business & Finance > Investments > Stocks (A to Z) > Stocks I > Inhibitex, Inc. (INHX)
Re: Its simply undervalued. What if one of the key milestones included Inhibitx
staph patent porfolio? Nabi Biopharmaceuticals has
struck a deal to sell off another big piece of itself.
GlaxoSmithKline agreed... Business & Finance > Investments > Stocks (A to Z) > Stocks I > Inhibitex, Inc. (INHX)
